Interstitial lung disease Trials in New York, United States
Conditions / Interstitial lung disease / New York, United States
Interstitial lung disease has been the subject of sustained clinical investigation across multiple research sites.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04905693 | Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | ENROLLING_BY_INVITATION | PHASE3 |
| NCT05270668 | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | RECRUITING | — |
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | RECRUITING | — |
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | RECRUITING | — |
| NCT03295279 | WTC Chest CT Imaging Archive | RECRUITING | — |
| NCT02036970 | Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT | COMPLETED | PHASE2 |
| NCT00362739 | Blood Collection From Individuals With Lung Disease for Genetic Studies | COMPLETED | — |
| NCT02630316 | Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE | COMPLETED | PHASE2/PHASE3 |
| NCT02633293 | An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE | TERMINATED | PHASE2/PHASE3 |